Peripheral blood dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART
M Otero, G Nunnari, D Leto, J Sullivan… - AIDS research and …, 2003 - liebertpub.com
M Otero, G Nunnari, D Leto, J Sullivan, FX Wang, I Frank, Y Xu, C Patel, G Dornadula…
AIDS research and human retroviruses, 2003•liebertpub.comDendritic cells (DCs) are potent antigen-presenting cells, and their physiological localization
in tissues that interact with the external environment is important as a first barrier against
pathogens such as human immunodeficiency virus type I (HIV-1). Several models have
been proposed to explain the possible role of DCs as a reservoir for HIV-1 in patients on
virally suppressive highly active antiretroviral therapy (HAART). However, the low yield of
cell isolates has made this evaluation a difficult task. The present study analyzes whether …
in tissues that interact with the external environment is important as a first barrier against
pathogens such as human immunodeficiency virus type I (HIV-1). Several models have
been proposed to explain the possible role of DCs as a reservoir for HIV-1 in patients on
virally suppressive highly active antiretroviral therapy (HAART). However, the low yield of
cell isolates has made this evaluation a difficult task. The present study analyzes whether …
Dendritic cells (DCs) are potent antigen-presenting cells, and their physiological localization in tissues that interact with the external environment is important as a first barrier against pathogens such as human immunodeficiency virus type I (HIV-1). Several models have been proposed to explain the possible role of DCs as a reservoir for HIV-1 in patients on virally suppressive highly active antiretroviral therapy (HAART). However, the low yield of cell isolates has made this evaluation a difficult task. The present study analyzes whether peripheral blood DCs from HIV-1-infected individuals on virally suppressive HAART, with plasma HIV-1 RNA levels of less than 50 copies/ml, carry either HIV-1 provirus and/or HIV-1 virions. Peripheral blood DCs were isolated from a cohort of 10 HIV-1-seropositive men taking suppressive HAART. In five patients, plasmacytoid and myeloid dendritic cells were isolated to attempt to identify their respective roles in HIV-1 residual disease. Viral out-growth assays were performed in vitro, as well as gag and R/U5 polymerase chain reaction (PCR) amplification of viral RNA and DNA, respectively, from DC and peripheral blood mononuclear cell (PBMC) extracts. Fluorescence activated cell-sorting (FACS) data revealed cellular yields from 85.90 to 95.18%, of relatively pure DCs isolated from patients' PBMCs. Although HIV-1 RNA gag and DNA RU/5 were detected in all PBMC samples isolated from the patients, proviral DNA and viral RNA forms were not detected in any of the DC isolates. In addition, no replication-competent virus was demonstrated in DC coculture assays, while virus was isolated from each patients' CD8+ T-lymphocyte-depleted PBMC cocultures. Furthermore, HIV-1 gag proviral DNA was not detected in either plasmacytoid or myeloid DC subfractions. The current study suggests that in HIV-1-infected individuals treated with suppressive HAART, peripheral blood DCs do not carry HIV-1 proviral DNA or viral particles attached to their surface. These populations of peripheral blood DCs are likely not a major HIV-1 reservoir in patients on HAART with clinically undetectable plasma viral RNA.
Mary Ann Liebert